The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Uptake of oophorectomy in women with findings on multigene panel testing: Results from the Prospective Registry of Multiplex Testing (PROMPT).
 
Susan M. Domchek
Honoraria - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst)
 
Jamie Brower
No Relationships to Disclose
 
Heather Symecko
No Relationships to Disclose
 
Vanessa Marcell
No Relationships to Disclose
 
Michael Francis Walsh
No Relationships to Disclose
 
Jada G. Hamilton
No Relationships to Disclose
 
Fergus Couch
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Ambry Genetics; Qiagen
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL; Qiagen
Other Relationship - Ambry Genetics
 
Kenneth Offit
Patents, Royalties, Other Intellectual Property - Diagnosis and treatment of ERCC3-mutant cancer; inventors: Joseph Vijai, Sabine Topka, Kenneth Offit; US National Stage Patent Application No.: 16/493,214; filing date: September 11, 2019 (Inst)
 
Judy Ellen Garber
Consulting or Advisory Role - Aleta BioTherapeutics (I); GTx (I); H3 Biomedicine (I); Helix BioPharma; Konica Minolta; Kronos Bio (I); Novartis (I)
Research Funding - Ambry Genetics; InVitae; Myriad Genetics; Novartis (I)
Other Relationship - AACR; Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; James P. Wilmot Foundation (I); Susan G. Komen for the Cure (I)
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - Change HealthCare
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
Other Relationship - Clinical Care Options; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo; Merck; Pfizer